We are live on ! Find out more
CAM

Concorde Asset Management Portfolio holdings

AUM $204M
This Fund
S&P 500
This Quarter Est. Return
+6.23%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$178M
AUM Growth
+$4.64M
Cap. Flow
-$3.14M
Cap. Flow %
-1.76%
Top 10 Hldgs %
24.01%
Holding
231
New
21
Increased
71
Reduced
95
Closed
37

Top Buys

Rank Stock Value
1
KKR icon
KKR & Co
KKR
+$2.34M
2
ORAN
Orange
ORAN
+$1.8M
3
BTI icon
British American Tobacco
BTI
+$1.39M
4
GSK icon
GSK
GSK
+$1.32M
5
BRT
BRT Apartments
BRT
+$1.19M

Sector Composition

Rank Sector Weight
1 Real Estate 10.68%
2 Consumer Staples 7.52%
3 Communication Services 7.37%
4 Technology 6.73%
5 Financials 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPN icon
151
Appian
APPN
$2.11B
$258K 0.14%
1,876
-1,064
-36% -$121K
CHMI
152
Cherry Hill Mortgage Investment Corp
CHMI
$82.3M
$255K 0.14%
25,891
+1,480
+6% +$14.7K
PG icon
153
Procter & Gamble
PG
$340B
$255K 0.14%
1,893
+110
+6% +$14.9K
CMO
154
DELISTED
Capstead Mortgage Corp.
CMO
$255K 0.14%
41,517
+1,429
+4% +$9.21K
REMX icon
155
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.91B
$254K 0.14%
2,994
+313
+12% +$25.3K
NVO
156
Novo Nordisk
NVO
$228B
$252K 0.14%
6,022
PINS icon
157
Pinterest
PINS
$13.7B
$252K 0.14%
3,186
-2,189
-41% -$153K
NEAR icon
158
iShares Short Maturity Bond ETF
NEAR
$4.82B
$250K 0.14%
4,005
-2,992
-43% -$150K
RTL
159
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$249K 0.14%
29,385
+2,739
+10% +$25.6K
CRSP icon
160
CRISPR Therapeutics
CRSP
$4.69B
$245K 0.14%
1,515
-1,330
-47% -$162K
GNTX icon
161
Gentex
GNTX
$5.1B
$245K 0.14%
7,400
-44
-0.6% -$1.53K
QUAL icon
162
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
$237K 0.13%
1,780
-240
-12% -$30.8K
NEOG icon
163
Neogen
NEOG
$2.05B
$233K 0.13%
5,058
-22
-0.4% -$1.02K
ABBV icon
164
AbbVie
ABBV
$465B
$230K 0.13%
2,019
-8,131
-80% -$916K
CSCO icon
165
Cisco
CSCO
$443B
$230K 0.13%
4,345
-1,447
-25% -$76.1K
GRWG icon
166
GrowGeneration
GRWG
$84.7M
$230K 0.13%
4,780
-67,072
-93% -$2.94M
SKYY icon
167
First Trust Cloud Computing ETF
SKYY
$2.83B
$228K 0.13%
2,153
-619
-22% -$62K
FTSM icon
168
First Trust Enhanced Short Maturity ETF
FTSM
$6.51B
$225K 0.13%
3,754
-331
-8% -$19.9K
FVRR icon
169
Fiverr
FVRR
$331M
$223K 0.13%
919
-1,060
-54% -$220K
HQY icon
170
HealthEquity
HQY
$8.71B
$223K 0.13%
2,770
-504
-15% -$38.4K
LIN icon
171
Linde
LIN
$236B
$223K 0.13%
770
PYPL icon
172
PayPal
PYPL
$49.9B
$222K 0.12%
+763
New +$202K
CAT icon
173
Caterpillar
CAT
$361B
$218K 0.12%
1,000
FSLY icon
174
Fastly Inc
FSLY
$3.24B
$218K 0.12%
3,652
-937
-20% -$53.2K
CQQQ icon
175
Invesco China Technology ETF
CQQQ
$3.01B
$215K 0.12%
2,557
-284
-10% -$23K

Similar funds

Concorde Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Concorde Asset Management held 231 positions worth $178M, up 2.7% from $173M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Concorde Asset Management's Q2 2021 filing shows 21 new, 71 increased, 95 reduced and 37 closed positions. Its largest new stake was KKR & Co: 42,252 shares worth $2.5M. The largest sale was GrowGeneration, an estimated $2.94M.

By sector, the portfolio is most concentrated in Real Estate at 11% of assets, up from 8.5% a quarter earlier, followed by Consumer Staples and Communication Services.

  • Concorde Asset Management's largest Q2 2021 buy was KKR & Co: 42,252 shares worth $2.5M.
  • Concorde Asset Management added most to Orange in Q2 2021, an estimated $1.8M increase.
  • Concorde Asset Management's biggest Q2 2021 reduction was GrowGeneration, cutting an estimated $2.94M.
  • Concorde Asset Management fully exited Prospect Capital in Q2 2021, selling an estimated $1.17M.
  • Concorde Asset Management's ten largest holdings make up 24% of its $178M portfolio in Q2 2021.
  • Concorde Asset Management opened 21 new positions and closed 37 in Q2 2021.
  • Concorde Asset Management's portfolio value rose 2.7% quarter-over-quarter to $178M.

Based on Concorde Asset Management's 13F filing for Q2 2021, filed 20 Jul 2021.